Schofield, Penelope, Gough, Karla, Duchesne, Gillian, Sanson-Fisher, Rob, Aranda, Sanchia, Lotfi-Jam, Kerryann, Bergin, Rebecca, Ugalde, Anna, Dudgeon, Paul, Crellin, Wallace, Schubach, Kathryn, Foroudi, Farshard, Tai, Keen Hun. BioMed Central; 2016. Nurse-led group consultation intervention reduces depressive symptoms in men with localised prostate cancer: a cluster randomised controlled trial.

Catton, Charles N., Lukka, Himu, Tai, Keen Hun, Wu, Jackson S., Parliament, Matthew B., Tsakiridis, Theodoros, Corbett, Tom B., Tang, Colin, Dayes, Ian S., Warde, Padraig, Craig, Tim K., Julian, Jim A., Gu, Chu-Shu, Levine, Mark N., Martin, Jarad M., Supiot, Stéphane, Chung, Peter W. M., Bauman, Glenn S., Bahary, Jean-Paul, Ahmed, Shahida, Cheung, Patrick. American Society of Clinical Oncology; 2017. Randomized trial of a hypofractionated radiation regimen for the treatment of localized prostate cancer.

Duchesne, Gillian M., Woo, Henry H., Millar, Jeremy, Milne, Roger, Smith, Rosemary G., Spry, Nigel, Stockler, Martin, Syme, Rodney A., Tai, Keen Hun, Turner, Sandra, Bassett, Julie K., Bowe, Steven J., D'Este, Catherine, Frydenberg, Mark, King, Madeleine, Ledwich, Leo, Loblaw, Andrew, Malone, Shawn. Elsevier; 2016. Timing of androgen-deprivation therapy in patients with prostate cancer with a rising PSA (TROG 03.06 and VCOG PR 01-03 [TOAD]): a randomised, multicentre, non-blinded, phase 3 trial.

Pryor, David I., Turner, Sandra L., Tai, Keen Hun, Tang, Colin, Sasso, Giuseppe, Dreosti, Marcus, Woo, Henry H., Wilton, Lee, Martin, Jarad M.. John Wiley & Sons; 2018. Moderate hypofractionation for prostate cancer: A user's guide.